Jubilant Chemsys Ltd (JCL); a company registered under the Indian Companies Act, 1956 offers services in synthetic, organic and medicinal chemistry areas to various pharmaceutical biotechnology, agrochemical and fine chemical companies. Jubilant Chemsys Limited (JCL) & Jubilant Biosys Limited (JBL); are sister concerns of Jubilant Life Sciences (a $1.3 Bn Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its research centers in India. Jubilant’s services in discovery research include; • Target Identification/ Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK, in-vitro and in-vivo biology and IND enabling GLP toxicology. 3. Key Statistics: • Founded in 2000; Worked with Global Top-10 Pharma, Mid-sized and Biotech companies with several collaboration running since 4 to 9 years. • 600+ people working on drug discovery services business. • 75+ integrated programs experience with 12 successfully delivered at Lead Optimization/ IND stage. • Multi-location: Research centers spread across locations in Noida and Bengaluru in India. • Customized business models fit to serve customer needs; o Full Time Equivalent (FTE) based, o Fee For Service (FFS) based, o Risk share and Milestone based for integrated research programs. http://www.jubilantbiosys.com/downloads/presentation#popup167